Prof. Dr. Yusuf OĞUZ

1. Plasma sTWEAK levels in chronic kidney disease stages Niveles plasmáticos de sTWEAK en estadios de enfermedad renal crónica

GÖK M., Cetinkaya H., OĞUZ Y.

Revista de Nefrologia, Dialisis y Trasplante , cilt.42, sa.2, ss.103-108, 2022 (SCI-Expanded, Scopus)

2. The association of profilin-1 levels with survival in chronic kidney disease

Eroglu E., Unal H. U., Guclu A., KOÇYİĞİT İ., Karaman M., Saglam M., et al.

European Journal of Clinical Investigation , cilt.47, sa.12, 2017 (SCI-Expanded, Scopus)

3. IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival

Gungor O., Unal H. U., Guclu A., Gezer M., Eyileten T., Guzel F. B., et al.

PLoS ONE , cilt.12, sa.6, 2017 (SCI-Expanded, Scopus)

4. Thyroid function and cardiovascular events in chronic kidney disease patients

Afsar B., Yilmaz M. I., Siriopol D., Unal H. U., Saglam M., Karaman M., et al.

Journal of Nephrology , cilt.30, sa.2, ss.235-242, 2017 (SCI-Expanded, Scopus)

5. Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival

Kanbay M., Afsar B., Siriopol D., Unal H. U., Karaman M., Saglam M., et al.

European Journal of Internal Medicine , cilt.33, ss.81-87, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

6. Osteoprotegerin in Chronic Kidney Disease: Associations with Vascular Damage and Cardiovascular Events

Yilmaz M. I., Siriopol D., Saglam M., Unal H. U., Karaman M., Gezer M., et al.

Calcified Tissue International , cilt.99, sa.2, ss.121-130, 2016 (SCI-Expanded, Scopus)

7. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients

Kanbay M., Afsar B., Siriopol D., Unal H. U., Karaman M., Saglam M., et al.

International Urology and Nephrology , cilt.48, sa.7, ss.1129-1136, 2016 (SCI-Expanded, Scopus)

8. Rituximab therapy for primary glomerulonephritis: A report of 5 cases Primer glomerülonefritlerde rituximab tedavisi: 5 olgu sunumu

Ünal H. U., Karaman M., Yilmaz M. I., Eyleten T., Özcan A., Vural A., et al.

Turkish Nephrology, Dialysis and Transplantation Journal , cilt.25, ss.155-158, 2016 (Scopus, TRDizin)

9. The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease

Sonmez A., Yilmaz M. I., Saglam M., Unal H. U., GÖK M., Cetinkaya H., et al.

Lipids in Health and Disease , cilt.14, sa.1, 2015 (SCI-Expanded, Scopus)

10. A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation

Yilmaz M. I., Sonmez A., Saglam M., Cayci T., Kilic S., Unal H. U., et al.

Clinical Journal of the American Society of Nephrology , cilt.10, sa.3, ss.471-479, 2015 (SCI-Expanded, Scopus)

11. Ramipril lowers plasma FGF-23 in patients with diabetic nephropathy

Yilmaz M. I., Sonmez A., Saglam M., Kurt Y. G., Unal H. U., Karaman M., et al.

American Journal of Nephrology , cilt.40, sa.3, ss.208-214, 2014 (SCI-Expanded, Scopus)

12. Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients

Kanbay M., Siriopol D., Saglam M., Kurt Y. G., GÖK M., Cetinkaya H., et al.

Journal of Clinical Endocrinology and Metabolism , cilt.99, sa.10, 2014 (SCI-Expanded, Scopus)

13. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease

Kanbay M., Solak Y., Unal H. U., Kurt Y. G., GÖK M., Cetinkaya H., et al.

International Urology and Nephrology , cilt.46, sa.8, ss.1619-1625, 2014 (SCI-Expanded, Scopus)

14. Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events

Yilmaz M. I., Demirkaya E., Acikel C., Saldir M., Akar S., Cayci T., et al.

Rheumatology (United Kingdom) , cilt.53, sa.11, ss.2002-2008, 2014 (SCI-Expanded, Scopus)

15. The importance of immuneofluorescence staining in patients with primary FSGS

Ünal H. U., Çakar M., Yavan I., Kiliç S., Özcan A., Yilmaz M. I., et al.

Turkish Nephrology, Dialysis and Transplantation Journal , cilt.23, sa.1, ss.51-55, 2014 (Scopus, TRDizin)

16. The relationship between IL-10 levels and cardiovascular events in patients with CKD

Yilmaz M. I., Solak Y., Saglam M., Cayci T., Acikel C., Unal H. U., et al.

Clinical Journal of the American Society of Nephrology , cilt.9, sa.7, ss.1207-1216, 2014 (SCI-Expanded, Scopus)

17. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease

Yilmaz M. I., Siriopol D., Saglam M., Kurt Y. G., Unal H. U., Eyileten T., et al.

Kidney International , cilt.86, sa.6, ss.1213-1220, 2014 (SCI-Expanded, Scopus)

18. A rare cause of post-exercise acute renal failure: Renal hipouricemia Egzersi̇z sonrasi akut böbrek yetmezli̇ǧi̇ni̇n nadi̇r bi̇r nedeni̇: Renal hi̇poüri̇semi̇

Ünal H. U., Çakar M., GÖK M., Yilmaz M. I., Eyileten T., Çaǧlar K., et al.

Anatolian Journal of Clinical Investigation , cilt.7, sa.4, ss.225-227, 2013 (Scopus)

19. Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function

Yilmaz M. I., Sonmez A., Saglam M., Yaman H., Unal H. U., GÖK M., et al.

European Journal of Clinical Investigation , cilt.43, sa.12, ss.1250-1257, 2013 (SCI-Expanded, Scopus)

20. Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease

Solak Y., Yilmaz M. I., Sonmez A., Saglam M., Cakir E., Unal H. U., et al.

Clinical and Experimental Nephrology , cilt.17, sa.4, ss.532-540, 2013 (SCI-Expanded, Scopus)

21. Longitudinal analysis of vascular function and biomarkers of metabolic bone disorders before and after renal transplantation

Yilmaz M. I., Sonmez A., Saglam M., Yaman H., Kilic S., Turker T., et al.

American Journal of Nephrology , cilt.37, sa.2, ss.126-134, 2013 (SCI-Expanded, Scopus)

22. Mean corpuscular volume is associated with endothelial dysfunction and predicts composite cardiovascular events in patients with chronic kidney disease

Solak Y., Yilmaz M. I., Saglam M., Demirbas S., Verim S., Unal H. U., et al.

Nephrology , cilt.18, sa.11, ss.728-735, 2013 (SCI-Expanded, Scopus)

23. Renal cell carcinoma in a transplanted kidney after 29 years: A case report and review of the literature Transplante Böbrekte 29 yil Sonra Renal Hücreli Karsinoma: Bir Olgu Sunumu ve Literatürün Gözden Geçirilmesi

Ünal H. U., GÖK M., Yilmaz M. I., Eyileten T., Çaǧlar K., OĞUZ Y., et al.

Turkish Nephrology, Dialysis and Transplantation Journal , cilt.21, sa.3, ss.295-297, 2012 (Scopus, TRDizin)

24. Serum uric acid independently predicts cardiovascular events in advanced nephropathy

Kanbay M., Yilmaz M. I., Sonmez A., Solak Y., Saglam M., Cakir E., et al.

American Journal of Nephrology , cilt.36, sa.4, ss.324-331, 2012 (SCI-Expanded, Scopus)

25. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients

Kanbay M., Yilmaz M. I., Apetrii M., Saglam M., Yaman H., Unal H. U., et al.

American Journal of Nephrology , cilt.36, sa.3, ss.228-237, 2012 (SCI-Expanded, Scopus)

26. The spitzer-weinstein syndrome: One form of type IV renal tubular acidosis and its response to indapamide: A case report Spitzer-weinstein sendromu: Tip 4 renal tubuler asidozun bir formu ve i̇ndapamide cevabi: Bir olgu sunumu

Ünal H. U., GÖK M., Yilmaz M. I., Eyileten T., OĞUZ Y., Çaǧlar K., et al.

Turkish Nephrology, Dialysis and Transplantation Journal , cilt.21, sa.2, ss.201-204, 2012 (Scopus, TRDizin)

27. Comparison of calcium acetate and sevelamer on vascular function and fibroblast growth factor 23 in CKD patients: A randomized clinical trial

Yilmaz M. I., Sonmez A., Saglam M., Yaman H., Kilic S., Eyileten T., et al.

American Journal of Kidney Diseases , cilt.59, sa.2, ss.177-185, 2012 (SCI-Expanded, Scopus)

28. Methotrexate-induced pancytopenia in two patients with renal dysfunction Böbrek i̇şlevleri bozuk i̇ki olguda metotreksat kullanimina baǧli pansitopeni gelişmesi

OĞUZ Y., Eyileten T., Karaman M., Ay S. A., Yilmaz M. I.

Turkish Nephrology, Dialysis and Transplantation Journal , cilt.20, sa.1, ss.93-95, 2011 (Scopus, TRDizin)

29. Vascular health, systemic inflammation and progressive reduction in kidney function; Clinical determinants and impact on cardiovascular outcomes

Yilmaz M. I., Stenvinkel P., Sonmez A., Saglam M., Yaman H., Kilic S., et al.

Nephrology Dialysis Transplantation , cilt.26, sa.11, ss.3537-3543, 2011 (SCI-Expanded, Scopus)

30. Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease

Yilmaz M. I., Sonmez A., Qureshi A. R., Saglam M., Stenvinkel P., Yaman H., et al.

Clinical Journal of the American Society of Nephrology , cilt.6, sa.7, ss.1617-1625, 2011 (SCI-Expanded, Scopus)

31. Soluble TWEAK and PTX3 in nondialysis CKD patients: Impact on endothelial dysfunction and cardiovascular outcomes

Yilmaz M. I., Sonmez A., Ortiz A., Saglam M., Kilic S., Eyileten T., et al.

Clinical Journal of the American Society of Nephrology , cilt.6, sa.4, ss.785-792, 2011 (SCI-Expanded, Scopus)

32. Low triiodothyronine alters flow-mediated vasodilatation in advanced nondiabetic kidney disease

Yilmaz M. I., Sonmez A., Karaman M., Ay S. A., Saglam M., Yaman H., et al.

American Journal of Nephrology , cilt.33, sa.1, ss.25-32, 2011 (SCI-Expanded, Scopus)

33. Reduced proteinuria using ramipril in diabetic CKD stage 1 decreases circulating cell death receptor activators concurrently with ADMA. A novel pathophysiological pathway?

Yilmaz M. I., Sonmez A., Saglam M., Yaman H., Cayci T., Kilic S., et al.

Nephrology Dialysis Transplantation , cilt.25, sa.10, ss.3250-3256, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Predictors of carotid artery intima-media thickness in chronic kidney disease and kidney transplant patients without overt cardiovascular disease

Yilmaz M. I., Qureshi A. R., Carrero J. J., Saglam M., Suliman M. E., Caglar K., et al.

American Journal of Nephrology , cilt.31, sa.3, ss.214-221, 2010 (SCI-Expanded, Scopus)

35. Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy

Eyileten T., Sonmez A., Saglam M., Cakir E., Caglar K., OĞUZ Y., et al.

Nephrology , cilt.15, sa.2, ss.225-229, 2010 (SCI-Expanded, Scopus)

36. The relationship between hemoglobin levels and endothelial functions in diabetes mellitus

Sonmez A., Yilmaz M. I., Saglam M., Kilic S., Eyileten T., Uckaya G., et al.

Clinical Journal of the American Society of Nephrology , cilt.5, sa.1, ss.45-50, 2010 (SCI-Expanded, Scopus)

37. FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease

Yilmaz M. I., Sonmez A., Saglam M., Yaman H., Kilic S., Demirkaya E., et al.

Kidney International , cilt.78, sa.7, ss.679-685, 2010 (SCI-Expanded, Scopus)

38. Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage?

Yilmaz M. I., Saglam M., Carrero J. J., Qureshi A. R., Caglar K., Eyileten T., et al.

Clinical Transplantation , cilt.23, sa.2, ss.241-248, 2009 (SCI-Expanded, Scopus)

39. Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria

Yilmaz M. I., Axelsson J., Sonmez A., Carrero J. J., Saglam M., Eyileten T., et al.

Clinical Journal of the American Society of Nephrology , cilt.4, sa.3, ss.535-541, 2009 (SCI-Expanded, Scopus)

40. Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease

Yilmaz M. I., Sonmez A., Saglam M., GÜLEÇ M., Kilic S., Eyileten T., et al.

Kidney International , cilt.75, sa.12, ss.1316-1321, 2009 (SCI-Expanded, Scopus)

41. The relationship between adiponectin levels and degree of proteinuria in patients with nephrotic and non-nephrotic proteinuria

OĞUZ Y., Yilmaz M. I., Acikel C., Eyileten T., Caglar K., Oktenli C., et al.

Renal Failure , cilt.31, sa.1, ss.29-35, 2009 (SCI-Expanded, Scopus)

42. CMV-induced severe acute hemorrhagic cystitis in a renal transplant patient CMV'un neden olduǧu ciddi akut hemorajik sistitli bir renal transplant olgusu

OĞUZ Y., Ilker Yilmaz M., Eyileten T., Çaǧlar K., Öktenli Ç., Yenicesu M., et al.

Gulhane Medical Journal , cilt.51, sa.3, ss.190-191, 2009 (Scopus, TRDizin)

43. Renal Behçet's Disease: An Update

Akpolat T., Dilek M., Aksu K., Keser G., Toprak Ö., Cirit M., et al.

Seminars in Arthritis and Rheumatism , cilt.38, sa.3, ss.241-248, 2008 (SCI-Expanded, Scopus)

44. Endothelial dysfunction in type-2 diabetics with early diabetic nephropathy is associated with low circulating adiponectin

Yilmaz M. I., Saglam M., Qureshi A. R., Carrero J. J., Caglar K., Eyileten T., et al.

Nephrology Dialysis Transplantation , cilt.23, sa.5, ss.1621-1627, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

45. Hyperbaric oxygen treatment augments the efficacy of cilazapril and simvastatin regimens in an experimental nephrotic syndrome model

Sonmez A., Yilmaz M. I., KORKMAZ A., Topal T., Caglar K., Kaya A., et al.

Clinical and Experimental Nephrology , cilt.12, sa.2, ss.110-118, 2008 (Scopus)

46. Serum fetuin-A concentration and endothelial dysfunction in chronic kidney disease

Caglar K., Yilmaz M. I., Saglam M., Cakir E., Kilic S., Sonmez A., et al.

Nephron - Clinical Practice , cilt.108, sa.3, 2008 (SCI-Expanded, Scopus)

47. ADMA levels correlate with proteinuria, secondary amyloidosis, and endothelial dysfunction

Yilmaz M. I., Sonmez A., Saglam M., Qureshi A. R., Carrero J. J., Caglar K., et al.

Journal of the American Society of Nephrology , cilt.19, sa.2, ss.388-395, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Short-term treatment with sevelamer increases serum fetuin-A concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients

Caglar K., Yilmaz M. I., Saglam M., Cakir E., Acikel C., Eyileten T., et al.

Clinical Journal of the American Society of Nephrology , cilt.3, sa.1, ss.61-68, 2008 (SCI-Expanded, Scopus)

49. Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: Ramipril versus valsartan

Yilmaz M. I., Saglam M., Sonmez A., Caglar K., Cakir E., Kurt Y., et al.

Blood Purification , cilt.25, sa.4, ss.327-335, 2007 (SCI-Expanded, Scopus)

58. Acute renal allograft dysfunction due to acute pyelonephritis Akut pyelonefri̇te baǧli akut allograft di̇sfonksi̇yonu (i̇ki̇ olgu nedeni̇ i̇le)

Avci A., OĞUZ Y., Özgök I. Y., BEDİR S., Yenicesu M., Vural A., et al.

Gulhane Medical Journal , cilt.46, sa.3, ss.251-254, 2004 (Scopus, TRDizin)

59. Peroxisome proliferator-activated receptor γ (PPAR-γ) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria

Yilmaz M. I., Sonmez A., Caglar K., Gok D. E., Eyileten T., Yenicesu M., et al.

Endocrine , cilt.25, sa.3, ss.207-214, 2004 (SCI-Expanded, Scopus)

60. Reverse iontophoresis: A non-invasive technique for measuring blood urea level

Degim I. T., İLBASMIŞ TAMER S., Dundaroz R., OĞUZ Y.

Pediatric Nephrology , cilt.18, sa.10, ss.1032-1037, 2003 (Scopus)

61. Behçet's disease and renal failure

Akpolat T., Diri B., OĞUZ Y., Yilmaz E., YAVUZ M., Dilek M.

Nephrology Dialysis Transplantation , cilt.18, sa.5, ss.888-891, 2003 (Scopus)

62. The midnight-to-morning urinary cortisol increment method is not reliable for the assessment of hypothalamic-pituitary-adrenal insufficiency in patients with end-stage kidney disease

OĞUZ Y., Oktenli C., Ozata M., ÖZGÜRTAŞ T., Sanisoglu Y., Yenicesu M., et al.

Journal of Endocrinological Investigation , cilt.26, sa.7, ss.609-615, 2003 (SCI-Expanded, Scopus)

68. Observations on edema formation and resolution in Gleich syndrome: Essential role of the kidneys in effective arterial blood volume regulation

Oktenli C., Bulucu F., Gurbuz M., Bozoglu E., OĞUZ Y., Koc B.

American Journal of Nephrology , cilt.21, sa.2, ss.154-161, 2001 (Scopus)

69. Seroconversion rates of two different doses of hepatitis b vaccine in turkish haemodialysis patients

OĞUZ Y., Doganci L., Vural A.

Central European Journal of Public Health , cilt.9, sa.1, ss.44-45, 2001 (Scopus)

70. Noninfectious complications in renal transplant patients Renal transplantli olgularda gelisen infeksiyon disi komplikasyonlar

OĞUZ Y., Vural A., Bulucu F., Yenicesu M., Caglar K., Oktenli C.

Gulhane Medical Journal , cilt.42, sa.3, ss.263-268, 2000 (Scopus, TRDizin)

71. Oral and intradialytic parenteral essenial amino acid therapy in hemodialysis patients with malnutrition Malnutrisyonlu kronik hemodiyaliz hastalarinda oral ve parenteral esansiyel amino asit tedavisi

OĞUZ Y., Vural A., Sengel O., Akbayrak N., Bulucu F., Yenicesu M., et al.

Ondokuz Mayis Universitesi Tip Dergisi , cilt.15, sa.4, ss.306-311, 1998 (Scopus, TRDizin)

72. Detection of source of haematuria after extracorporeal shock wave lithotripsy (ESWL) by automated measurement of urinary red cell volume

Vural A., OĞUZ Y., Oktenli C., Yenicesu M., Caglar K., Tanboga H.

International Urology and Nephrology , cilt.30, sa.1, ss.31-37, 1998 (Scopus)

73. Anticardiolipin antibodies in nondialyzed chronic renal failure patients Diyalize baslanmamis kronik bobrek yetmezliklilerde antikardiyolipin antikor sikligi

Bulucu F., Vural A., Yesilova Z., Sengul A., Yenicesu M., OĞUZ Y., et al.

Ondokuz Mayis Universitesi Tip Dergisi , cilt.15, sa.3, ss.216-220, 1998 (Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Tez Danışmanlığı